Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Circulation. Cardiovascular Imaging|April 19, 2013
Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardiumLee Fong Ling, Thomas H Marwick, Demetrio Roland Flores, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 24, 2010
Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patientsDeborah H Kwon, Manuel D Cerqueira, Ron Young, et al.JACC. Cardiovascular Imaging|August 22, 2017
Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac SarcoidosisBrett W Sperry, Balaji K Tamarappoo, Jorge D Oldan, et al.Circulation. Cardiovascular Imaging|October 3, 2014
Myocardial perfusion imaging in emergency department patients with negative cardiac biomarkers: yield for detecting ischemia, short-term events, and impact of downstream revascularization on mortalityPaul C Cremer, Shaden Khalaf, Shikhar Agarwal, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 8, 2014
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trialsJohn J Mahmarian, Leif E Peterson, Jiaqiong Xu, et al.JACC. Cardiovascular Imaging|September 18, 2017
Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on MortalityBrett W Sperry, Michael N Vranian, Albree Tower-Rader, et al.JACC. Cardiovascular Imaging|August 15, 2009
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trialJohn J Mahmarian, Manuel D Cerqueira, Ami E Iskandrian, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 6, 2012
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imagingEric S Ketchum, Arnold F Jacobson, James H Caldwell, et al.Journal of the American College of Cardiology|March 2, 2010
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) studyArnold F Jacobson, Roxy Senior, Manuel D Cerqueira, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 11, 2007
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trialAmi E Iskandrian, Timothy M Bateman, Luiz Belardinelli, et al.Pageof 6